Effectiveness and complications of 188Re-HEDP in palliative treatment of diffuse skeletal metastases

سال انتشار: 1394
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 259

فایل این مقاله در 5 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IRJNM-23-1_007

تاریخ نمایه سازی: 21 بهمن 1398

چکیده مقاله:

Introduction: Bone metastases are the most common cause of cancer-related pain in various primary malignant tumors, most often, breast and prostate. 188Re-hydroxyethylidene diphosphonate (188Re-HEDP) is a new and less expensive bone seeking radiopharmaceutical with favorable physical characteristics of the radionuclide such as short half life of 16.9h, maximal β energy of 2.1 MeV with a 15% γ-component of 155 keV and easily available from an in-house 188W/188Re generator. The aim of this study is to evaluate the therapeutic efficacy and safety profile of bone palliative therapy following administration of 188Re-HEDP. Methods: Twenty patients with painful metastatic bone lesions secondary to breast, prostate, multiple myeloma, ampulla of vater and lung cancers received 1 mCi/kg of 188Re-HEDP. Four hours after treatment, post-therapy scintigraphy was performed. All patients were interviewed using a standard set of questions (visual analogue scale: VAS) concerning their pain relief before, and after therapy at weekly intervals for the first month and every 2 weeks for the following 4 months. The general condition of the patients was also evaluated by Karnofsky-index and ECOG (Eastern Cooperative Oncology Group) performance status. Hematologic profiles were recorded before treatment and every two weeks up to 8 weeks after treatment. Results: Overall pain relief was found in 68.8% of patients. Decreased from 8.37±2.12 to 5.68±2.98 at VAS was observed 4 weeks after treatment. The osteoblastic lesions (breast and prostate) showed rather similar response to the treatment. Mean platelet counts decreased in 6th week and returned to baseline level in 8th week. One patient showed grade III leukopenia without any serious complication. Conclusion: 188Re-HEDP is an effective radiopharmaceutical for metastatic bone pain palliation therapy. Side effects include mild and transient thrombocytopenia and leucopenia and no life threatening side effect is observed.

نویسندگان

Davood Beiki

Research Center for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran

Maryam Tajik

Research Center for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran

Peiman Haddad

Department of Radiation Oncology, Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran

Babak Fallahi

Research Center for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Finlay IG, Mason MD, Shelley M. Radioisotopes for the palliation ...
  • Chiacchio S, Mazzarri S, Lorenzoni A, Nyakale N, Boni G, ...
  • Lam MG, de Klerk JM, van Rijk PP, Zonnenberg BA. ...
  • Liepe K, Runge R, Kotzerke J. The benefit of bone-seeking ...
  • Liepe K, Kotzerke J. A comparative study of 188Re-HEDP, 186Re-HEDP, ...
  • Baczyk M, Czepczyński R, Milecki P, Pisarek M, Oleksa R, ...
  • Lin WY, Lin CP, Yeh SJ, Hsieh BT, Tsai ZT, ...
  • Palmedo H, Guhlke S, Bender H, Sartor J, Schoeneich G, ...
  • Lewington VJ. Bone-seeking radionuclides for therapy. J Nucl Med. 2005 ...
  • Pirayesh E, Amoui M, Mirzaee HR, Tabei F, Rakhsha A, ...
  • Beiki D, Haddad P, Fallahi B, Keyvan A, Gholamrezanezhad A, ...
  • Bahrami-Samani A, Ghannadi-Maragheh M, Jalilian AR, Shirvani-Arani S, Meftahi M, ...
  • Bahrami-Samania A, Anvarib A, Jalilian AR, Shirvani-Arani S, Yousefnia H, ...
  • Liang JG, Jiang NY, DU JQ, Lu XP, Liu XG, ...
  • Cheng A, Chen S, Zhang Y, Yin D, Dong M. ...
  • Liepe K, Franke WG, Kropp J, Koch R, Runge R, ...
  • Liepe K, Kropp J, Runge R, Kotzerke J. Therapeutic efficiency ...
  • Li S, Liu J, Zhang H, Tian M, Wang J, ...
  • Biersack HJ, Palmedo H, Andris A, Rogenhofer S, Knapp FF, ...
  • Zhang H, Tian M, Li S, Liu J, Tanada S, ...
  • نمایش کامل مراجع